E-LIB Suche - Ergebnisse für: Desramé, Jérôme

1

Clinico-biological factors predicting the benefit of the LV..:

Boisteau, Emeric ; Dahan, Laetitia ; Williet, Nicolas...
The Oncologist. , 2024

2

Atezolizumab plus modified docetaxel, cisplatin, and fluoro..:

Kim, Stefano ; Ghiringhelli, Francois ; de la Fouchardière, Christelle...
The Lancet Oncology. 25 (2024) 4 - p. 518-528 , 2024

Link: https://doi.org/10.1016/..

3

Fatigue visual analogue scale score correlates with quality..:

Desramé, Jerome ; Baize, Nathalie ; Anota, Amélie...
Cancer Treatment and Research Communications. 37 (2023) - p. 100781 , 2023

Link: https://doi.org/10.1016/..

4

Preliminary tolerance analysis of adjuvant chemotherapy in ..:

Aparicio, Thomas ; Bouché, Olivier ; Etienne, Pierre-Luc...
Digestive and Liver Disease. 55 (2023) 4 - p. 541-548 , 2023

Link: https://doi.org/10.1016/..

5

DCF versus doublet chemotherapy as first-line treatment of ..:

Kim, Stefano ; Vendrely, Véronique ; Saint, Angélique...
Experimental Hematology & Oncology. 12 (2023) 1 - p. , 2023

Link: https://doi.org/10.1186/..

6

Safety of FOLFIRI + Durvalumab +/− Tremelimumab in Second L..:

Evrard, Camille ; Aparicio, Thomas ; Soularue, Emilie...
Biomedicines. 10 (2022) 5 - p. 1211 , 2022

Link: https://doi.org/10.3390/..

7

Second-line treatment after docetaxel, cisplatin and 5-fluo..:

Stouvenot, Morgane ; Meurisse, Aurélia ; Saint, Angélique...
European Journal of Cancer. 162 (2022) - p. 138-147 , 2022

Link: https://doi.org/10.1016/..

8

PRODIGE 59-DURIGAST trial: A randomised phase II study eval..:

Evrard, Camille ; Louvet, Christophe ; Hajbi, Farid EL...
Digestive and Liver Disease. 53 (2021) 4 - p. 420-426 , 2021

Link: https://doi.org/10.1016/..

9

Prognostic value of the early change in neutrophil-to-lymph..:

McLellan, Paul ; Henriques, Julie ; Ksontini, Feryel...
Clinics and Research in Hepatology and Gastroenterology. 45 (2021) 3 - p. 101541 , 2021

Link: https://doi.org/10.1016/..

10

Aflibercept in Combination With FOLFIRI as First-line Chemo..:

Lapeyre-Prost, Alexandra ; Pernot, Simon ; Sigrand, Julie...
Clinical Colorectal Cancer. 19 (2020) 4 - p. 285-290 , 2020

Link: https://doi.org/10.1016/..

11

Pooled analysis of 115 patients from updated data of Epitop..:

Kim, Stefano ; Meurisse, Aurélia ; Spehner, Laurie...
Therapeutic Advances in Medical Oncology. 12 (2020) - p. 175883592097535 , 2020

Link: https://doi.org/10.1177/..

12

Three fluoropyrimidine-based regimens in routine clinical p..:

Pointet, Anne-Laure ; Tougeron, David ; Pernot, Simon...
Clinics and Research in Hepatology and Gastroenterology. 44 (2020) 3 - p. 295-301 , 2020

Link: https://doi.org/10.1016/..

13

Nal-IRI/LV5-FU versus paclitaxel as second-line therapy in ..:

Randrian, Violaine ; Adenis, Antoine ; Desrame, Jérôme...
Digestive and Liver Disease. 52 (2020) 3 - p. 347-350 , 2020

Link: https://doi.org/10.1016/..

14

Incidence of Venous Thromboembolism in Patients With Newly ..:

Frere, Corinne ; Bournet, Barbara ; Gourgou, Sophie...
Gastroenterology. 158 (2020) 5 - p. 1346-1358.e4 , 2020

Link: https://doi.org/10.1053/..

15

Atezolizumab plus modified docetaxel-cisplatin-5-fluorourac..:

Kim, Stefano ; Buecher, Bruno ; André, Thierry...
BMC Cancer. 20 (2020) 1 - p. , 2020

Link: https://doi.org/10.1186/..